Source: International Congress 2018 – Cystic fibrosis in adults: current research



Rating:

Share or cite this content

Citations should be made in the following way:
A. Abdul Wahab (Doha, Qatar), M. Allangawi (Doha, Qatar), M. Thomas (Doha, Qatar), I. Bettahi (Doha, Qatar), S. Silvaraman (Doha, Qatar), J. Kumar (Doha, Qatar), P. Chandra (Doha, Qatar), M. Ramanjaneya (Doha, Qatar). Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation. 1334

Member's Comments

No comment yet.

Related content which might interest you: CFTR gene mutations detected in Japanese individuals with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 716s Year: 2006 KL-6 serum levels in adult cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 A novel CFTR mutation found in a Chinese cystic fibrosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 402s Year: 2005 High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and ΔF508 Source: Eur Respir J 2001; 17: 1181-1186 Year: 2001 Analysis of CFTR gene mutations in 24 Japanese individuals with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Serum lipid concentrations and malnutrition in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006 Distinctive CFTR gene mutations found in Japanese individuals with cystic fibrosis Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients Source: Eur Respir J 2004; 23: 679-684 Year: 2004 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles Source: ERJ Open Res, 5 (2) 00082-2019; 10.1183/23120541.00082-2019 Year: 2019 Serum microRNA levels in paediatric females versus males with cystic fibrosis Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Potentiating and correcting mutant CFTR in patients with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 129-149 Year: 2014 Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2016; 47: 322-324 Year: 2016 Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Sputum induction in young cystic fibrosis patients Source: Eur Respir J 2001; 17: 832 Year: 2001 Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population Source: Eur Respir J, 56 (3) 2000558; 10.1183/13993003.00558-2020 Year: 2020 Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis patients with the CFTR I1234V mutation in a large kindred family Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012 Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation Source: Eur Respir Rev 2013; 22: 66-71 Year: 2013